GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Holding in Top 10
Increase
Decrease
Funds Holding
2,996
Funds Holding Change
+237
Funds Holding Growth
+9%
Value
$533B
Holding in Top 10
441
Top 10 Change
+6
Top 10 Growth
+1%
Value Growth
+1%
New
361
Increased
1,235
Reduced
1,224
Closed
93
Capital Inflow
$23.4B
Capital Outflow
$17.1B
Net Capital Flow
+$6.22B
Capital Flow Change
+$1.64B
Calls
$5.85B
Puts
$8.18B
Net Calls
-$2.33B
Put/Call Ratio
1.4